Approach Could Limit Toxicity of CAR T Therapy in Acute Myeloid Leukemia – Drug Discovery & Development
Drug Discovery & Development |
Approach Could Limit Toxicity of CAR T Therapy in Acute Myeloid Leukemia
Drug Discovery & Development A new approach pioneered at the University of Pennsylvania's Abramson Cancer Center may provide a new path towards treating Acute Myeloid Leukemia (AML) with CAR T cells. To treat AML, investigators have to target a specific protein – CD33 – that's … |
